Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2529083

The invention provides compounds of formula (I), the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2, and R3 are as defined herein; pharmaceutical compositions thereof; and use thereof in the treatment of, inter alia, conditions, diseases, and symptoms such as diabetes, dementia, Alzheimer's Disease, stroke, schizophrenia, depression, hair loss, and cancer.

La présente invention se rapporte à des composés répondant à la formule (I), leurs stéréoisomères et promédicaments, et les sels pharmaceutiquement acceptables de ces composés, stéréoisomères et promédicaments, R?1¿, R?2¿ et R?3¿ dans ladite formule (I) ayant les notations définies dans la demande; compositions pharmaceutiques les contenant ; et leur utilisation dans le traitement, entre autres, des affections, maladies et symptômes tels que le diabète, la démence, la maladie d'Alzheimer, les accidents vasculaires cérébraux, la schizophrénie, la dépression, l'alopécie et les cancers.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2034312

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.